Short description
Biotechnology company engaged in the extraction and distribution of psychoactive compounds, and developing natural health care products.
Description
HAVN Life Sciences is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support central nervous system health and enhance the capabilities of the mind.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Vancouver, British Columbia, Canada, North America
Founded on
January 1, 2020
Exited on
September 11, 2020
Went public on
September 11, 2020
Stock symbol
HAVN
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Cannot Access
Sign in for full access
Founders
Alexzander Samuelsson, Barinder Rasode